WU Xianfeng  

  • Chief Physician, Graduate Supervisor
  • Department: Nephrology
  • Research Area: Internal medicine
  • Research Interests: The prognosis of patients with end stage renal disease
  • Contact: xianfengwu2@163.com
  • Fellowship, Shanghai Sixth People's Hospital, Nephrology, 2015
  • MD from Sun Yat-sen Univerisity, 2013
  • PhD from Sun Yat-sen University, 2013
  • MA from Nanchang University, 2010
  • Director, Department of Nephrology, Shanghai Eighth People's Hospital
  1. Zhou L, Wang X, Zhan X, Feng X, Wang N, Peng F, Wen Y, Wu, X#. Serum chloride and mortality in patients on continuous ambulatory peritoneal dialsysis: a multi-center retrospective study. EClinicalMedinice, 2021, doi: 10.1016/j.eclinm.2021.101133.
  2. You J, Gu S, Su N, Feng X, Peng F, Xu Q, Zhan X, Wen Y, Wang X, Tian N, Wu X, Wang N#. Serum sodium to chloride ratio and mortality on continuous ambulatory peritoneal dialysis: a multi-center retrospective study. MedComm, 2024.
  3. Wu X, Jian G, Tang Y, Cheng H, Wang N, Wu J#. Asymptomatic hyperuricemia and incident congestive heart failure in elderly patients without comorbidities. Nutr Metab Cardiovasc Dis.2020, doi: 10.1016/j.numecd.2019.12.008.
  • 01/01/2015-12/31/2018
    National Natural Science Foundation of China, ¥470,000, 81460142
    miRNA-24c regulates VE-cadherin expression to promote renal fibrosis and its mechanisms.
    Role: Principal Investigator
  • 10/21/2022-12/31/2025
    Co-operation Foundation, ¥2,000,000, 2022-133
    Efficacy and safety of small molecule water in patients with asymptomatic hyperuricemia: a multicenter, randomized double-blind, placebo-controlled trial.
    Role: Principal Investigator